Commercial Services Healthcare Sector

Clearmind Medicine

Market Cap: US$5.1m

A clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.

IM Cannabis

Market Cap: CA$7.0m

Engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.

Sunshine Biopharma

Market Cap: US$5.1m

Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.

CanadaBis Capital

Market Cap: CA$6.9m

Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.

bioAffinity Technologies

Market Cap: US$5.0m

Engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.

Check-Cap

Market Cap: US$5.0m

A clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel.

Quoin Pharmaceuticals

Market Cap: US$5.0m

A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.

NeuroScientific Biopharmaceuticals

Market Cap: AU$7.7m

Engages in the research and development of novel peptide-based pharmaceutical products.

Therma Bright

Market Cap: CA$6.8m

Acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace.

Ayurcann Holdings

Market Cap: CA$6.8m

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

Core One Labs

Market Cap: CA$6.8m

Operates as a psychedelic research and development company.

Belluscura

Market Cap: UK£3.6m

Develops and commercialize oxygen related medical device products in the United States.

Reflect Scientific

Market Cap: US$4.8m

Through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide.

Centogene

Market Cap: US$4.8m

Provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific.

Chimeric Therapeutics

Market Cap: AU$7.4m

A clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia.

Sweet Earth Holdings

Market Cap: CA$6.6m

Does not have significant operations.

Genflow Biosciences

Market Cap: UK£3.5m

Operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium.

Ecofibre

Market Cap: AU$7.3m

Engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia.

SenesTech

Market Cap: US$4.8m

Engages in the development and commercialization of a technology for managing animal pest populations through fertility control.

dorsaVi

Market Cap: AU$7.3m

Engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States.

Epsilon Healthcare

Market Cap: AU$7.2m

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada.

Adial Pharmaceuticals

Market Cap: US$4.7m

A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.

Xenetic Biosciences

Market Cap: US$4.7m

A biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.

Valeo Pharma

Market Cap: US$4.6m

A specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceuticals and hospital specialty products for unmet medical needs in Canada.

CompuMed

Market Cap: US$4.6m

An enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities.

Burzynski Research Institute

Market Cap: US$4.6m

Engages in the research and development of antineoplaston drugs for the treatment of various cancers.

Aptose Biosciences

Market Cap: CA$6.3m

A clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States.

Delivra Health Brands

Market Cap: CA$6.3m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

Invex Therapeutics

Market Cap: AU$7.0m

A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.

Autonomix Medical

Market Cap: US$4.5m

A development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.

PD-Rx Pharmaceuticals

Market Cap: US$4.5m

Engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States.

Bakhu Holdings

Market Cap: US$4.5m

Produces, manufactures, and sells cannabis-related byproducts for medical, food additive, and recreational use.

Vycor Medical

Market Cap: US$4.5m

Designs, develops, and markets neurological medical devices and therapies in the United States and Europe.

Regional Health Properties

Market Cap: US$4.5m

Operates as a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living.

Caduceus Software Systems

Market Cap: US$4.5m

Through its subsidiary, McLovin's Pet Food, Inc., operates as a pet food and pet care company.

WEED

Market Cap: US$4.5m

Focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia.